Valerie Calenda, Managing Partner at Mérieux Equity Partners, Lyon, Rhone-Alpes, France — verified investor profile. See sector focus and contact routes.
Valérie Calenda serves as Managing Partner at Mérieux Equity Partners, a Lyon-based venture capital firm focused on health and nutrition sectors. The firm manages over €700 million across innovation and development funds, targeting companies with high growth potential and significant public health impact. Calenda’s investment thesis centers on health and nutrition, supporting businesses developing high-value-added products or services. She has led or participated in notable rounds, including a €31 million Series A for Mablink Bioscience alongside Sofinnova Partners and Elaia. While specific check sizes and lead/follow patterns are not publicly detailed, her involvement in a €31 million round suggests capacity for substantial investments. Notable portfolio companies include Mablink Bioscience, a biotechnology firm in the health sector. Calenda has presented publicly on investment strategy, as seen in a conference titled “Conférence Stratégie Investissement” with François Valencony. No distinctive public writing or unique point of view beyond her firm’s stated focus on health and nutrition is currently documented in available sources.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Lyon.
Investors like Valerie Calenda · Full investor directory · Investor access · Company funding database